Eterna Therapeutics
ERNA
#10020
Rank
A$19.4 M
Marketcap
$0.31
Share price
-2.06%
Change (1 day)
-88.35%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of April 2025 : 7.29

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 21.3032.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-317.6475.7%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.20-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
3.20-56.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.31-131.71%๐Ÿ‡บ๐Ÿ‡ธ USA
1.59-78.25%๐Ÿ‡ซ๐Ÿ‡ท France
3.79-48.03%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-58.47%๐Ÿ‡ฆ๐Ÿ‡บ Australia
2.95-59.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel